Venn Life Sciences (VENN) Share Price, News & Analysis

Company Overview

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling. It also provides clinical trial services comprising clinical feasibility assessment, project management, clinical and medical monitoring, biometrics, biostatistics, data management and databases integration, ISC/IDMC, RTSM, investigator initiated studies, and resourcing and recruitment. In addition, the company offers regulatory affairs and consulting, quality assurance, and legal services, as well as drug development training and courses. The company has a strategic collaboration with Open Orphan DAC for the clinical research and regulatory consulting for companies developing products under the auspices of the various Orphan Drug frameworks. The company was founded in 2012 and is headquartered in Dublin, Ireland.

Key Stats

• Today's Range: N/A
• 50-Day Range: 6.85 to 6.85
• 52-Week Range: N/A
• Volume: 1.03 million shs
• Average Volume: 566,253 shs
• Market Capitalization: £4.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VENN Stock Analysis - Frequently Asked Questions

How do I buy shares of Venn Life Sciences?

Shares of VENN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Venn Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Venn Life Sciences investors own include Nielsen (NLSN), Bank of Hawaii (BOH), BJ's Wholesale Club (BJ), Biogen (BIIB), Bank of America (BAC), Arrow Electronics (ARW) and Art's-Way Manufacturing (ARTW).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: N/A
• Industry: Medical Care
• Sub-Industry: N/A
• Current Symbol: LON:VENN
• CIK: N/A
• Web: www.vennlifesciences.com
• Phone: +44-28-90737900
• Fax: N/A
• Employees: 157
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 35.83
• Current Ratio: 2.30
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: GBX 15.60 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 71,395,200
• Free Float: N/A
• Market Cap: £4.89 million
• Optionable: Not Optionable
• Beta: N/A